Exelixis Inc
Change company Symbol lookup
Select an option...
EXEL Exelixis Inc
SP SP Plus Corp
RHCGF Ryman Healthcare Ltd
CSCO Cisco Systems Inc
UTZ UTZ Brands Inc
BSQR Bsquare Corp
APYX Apyx Medical Corp
XPEV Xpeng Inc
STX Seagate Technology Holdings PLC
EL Estee Lauder Companies Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Exelixis, Inc. is an oncology focused biotechnology company. The Company is engaged in the discovery, development, and commercialization of medicines to treat cancers. Its cabozantinib molecule, is an inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors and RET. Cabozantinib is approved as CABOMETYX tablets used for advanced renal cell carcinoma (RCC), both alone and in combination with Bristol-Myers Squibb Company's (BMS) OPDIVO (nivolumab), for hepatocellular carcinoma (HCC) and for radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC). Cabozantinib is also approved as COMETRIQ capsules for metastatic medullary thyroid cancer (MTC). Its other two products are COTELLIC, an inhibitor of MEK approved as part of multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO an oral, non-steroidal, selective blocker of the mineralocorticoid receptor (MR) approved the treatment of hypertension.

Price
Delayed
$21.79
Day's Change
0.26 (1.21%)
Bid
--
Ask
--
B/A Size
--
Day's High
21.84
Day's Low
21.54
Volume
(Light)

Today's volume of 50,446 shares is on pace to be much lighter than EXEL's 10-day average volume of 2,880,347 shares.

50,446
  • Prev Close
    21.53
  • Today's Open
    21.54
  • Day's Range
    21.54-21.84
  • Avg Vol (10-day)
    2.9M
  • Last (time)
    9:47a ET 07/07/22
  • Last (size)
    146
  • 52-Wk Range
    15.50 - 23.40
    LowHigh
  • (12/06/21 - 04/05/22)
    6.88%
  • 39.4%
  • Market Cap
    7.0B
  • Shares Outstanding
    320.7M
  • 0.92
  • 24.13x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 85.80
  • (% of float 06/15/22)
    3.82

Latest News

July 07, 2022
5:20 am ET
Zacks
12:00 am ET
BusinessWire
July 05, 2022
4:05 pm ET
BusinessWire
June 21, 2022
8:00 am ET
BusinessWire
June 16, 2022
12:00 am ET
BusinessWire
May 31, 2022
4:05 pm ET
BusinessWire
May 26, 2022
5:00 pm ET
BusinessWire
5:00 pm ET
BusinessWire
May 10, 2022
4:05 pm ET
BusinessWire
May 04, 2022
4:05 pm ET
BusinessWire
May 03, 2022
8:00 am ET
BusinessWire
April 26, 2022
4:05 pm ET
BusinessWire
8:00 am ET
Globe Newswire
April 14, 2022
8:00 am ET
BusinessWire
April 13, 2022
4:05 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.